TY  - JOUR
AU  - Zuo, Hui
AU  - Ueland, Per M
AU  - Midttun, Øivind
AU  - Vollset, Stein E
AU  - Tell, Grethe S
AU  - Theofylaktopoulou, Despoina
AU  - Travis, Ruth C
AU  - Boutron-Ruault, Marie-Christine
AU  - Fournier, Agnès
AU  - Severi, Gianluca
AU  - Kvaskoff, Marina
AU  - Boeing, Heiner
AU  - Bergmann, Manuela M
AU  - Fortner, Renée T
AU  - Kaaks, Rudolf
AU  - Trichopoulou, Antonia
AU  - Kotanidou, Anastasia
AU  - Lagiou, Pagona
AU  - Palli, Domenico
AU  - Sieri, Sabina
AU  - Panico, Salvatore
AU  - Bueno-de-Mesquita, H Bas
AU  - Peeters, Petra H
AU  - Grankvist, Kjell
AU  - Johansson, Mikael
AU  - Agudo, Antonio
AU  - Garcia, Jose Ramon Quiros
AU  - Larranaga, Nerea
AU  - Sanchez-Perez, Maria-Jose
AU  - Chirlaque, Maria Dolores
AU  - Ardanaz, Eva
AU  - Chuang, Shu-Chun
AU  - Gallo, Valentina
AU  - Brennan, Paul
AU  - Johansson, Mattias
AU  - Ulvik, Arve
PY  - 2017
DO  - 10.1158/0008-5472.CAN-17-1923
UR  - http://hdl.handle.net/10668/11731
T2  - Cancer research
AB  - Circulating pyridoxal-5'-phosphate (PLP) has been linked to lung cancer risk. The PAr index, defined as the ratio 4-pyridoxic acid/(pyridoxal + PLP), reflects increased vitamin B6 catabolism during inflammation. PAr has been defined as a marker of...
LA  - en
KW  - Adult
KW  - Aged
KW  - Case-Control Studies
KW  - Europe
KW  - Female
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Pyridoxal Phosphate
KW  - Pyridoxic Acid
KW  - Risk Factors
KW  - Vitamin B 6
TI  - Results from the European Prospective Investigation into Cancer and Nutrition Link Vitamin B6 Catabolism and Lung Cancer Risk.
TY  - research article
VL  - 78
ER  -